Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News CAP XX Ltd (PK) CPXLF

Technology Electronic Components
CAP-XX Limited, together with its subsidiaries, develops, manufactures, and sells supercapacitors in the Asia Pacific, Europe, and the Americas. The company offers prismatic ultra-thin, lithium ion hybrid, cylindrical, and coin cell supercapacitors. Its products are used in the aerospace, transportation, green energy, electronics, industrial, and defense applications. The company was... see more

Current News (PINL:CPXLF)

No current news is available.
View More News ››

Opinion & Analysis (PINL:CPXLF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:CPXLF)

Be the first to post on this bullboard.

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms ...
View More »

Podcasts